NCT05250817View on ClinicalTrials.gov

A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

501

Participants

Timeline

Start Date

December 9, 2021

Primary Completion Date

January 4, 2023

Study Completion Date

January 4, 2023

Conditions
Carcinoma, Non-Small-Cell Lung
Trial Locations (1)

27709

RTI Health Solutions, Research Triangle Park

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05250817 - A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter